Connection

Axel Nierhaus to Biomarkers

Back to Details
This is a "connection" page, showing publications Axel Nierhaus has written about Biomarkers.
Axel Nierhaus
Connection Strength
0.209
Biomarkers
  1. Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFa response: A diagnostic tool for immunosuppression? PLoS One. 2017; 12(8):e0182427.
    View in: PubMed
    Score: 0.132
  2. MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers. 2021 Jul; 26(5):417-424.
    View in: PubMed
    Score: 0.042
  3. Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trial. Trials. 2019 Mar 04; 20(1):156.
    View in: PubMed
    Score: 0.009
  4. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival. Crit Care. 2018 09 19; 22(1):216.
    View in: PubMed
    Score: 0.009
  5. The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial. Crit Care. 2018 Mar 21; 22(1):79.
    View in: PubMed
    Score: 0.009
  6. Markers of nitric oxide are associated with sepsis severity: an observational study. Crit Care. 2017 Jul 15; 21(1):189.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.